¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-16
±³À°ÀÏÀÚ : 2021-04-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 8 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í ±³¼ö ¹× °³¿øÀÇ: 20000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ: 10000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ09:30~09:50 Optimal Choice and Duration of Antiplatelet Therapy in AMI  Á¤¿µÈÆ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ09:50~10:10 Timing of PCI for Nonculprit Lesion in STEMI  ÃÖö¿õ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ10:10~10:30 Intracoronary Imaging-Guided PCI Can Improve Outcomes in AMI?  À̼ºÀ±(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ10:30~10:50 Lipid Lowering Therapy in AMI: From Guidelines to Implementation  Á¶°æÈÆ(Àü³²ÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀΠ10:50~11:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04¿ù 16ÀÏ  11:00~11:10 Break  () 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ11:10~11:20 Mechanisms and Risk Factors of AF  ¹ÚÁø±Ô(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ11:20~11:30 AF screening: present and future  ÀÌÁ¤¸í(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ11:30~11:40 Medical Rhythm Control for AF  ¹ÚÇü¿í(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ11:40~11:50 Does Catheter Ablation of AF Improve Survival?  ¾çÇʼº(Â÷ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ11:50~12:00 Catheter Ablation of AF: Current Strategy  ¹ÚÇü¼·(°è¸íÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ12:00~12:10 Update in Cryoablation of AF as An Initial Treatment  ½ÉÀç¹Î(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ12:10~12:20 Treatment for Patients with AF and HF  ¾È¹Î¼ö(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀΠ12:20~12:40 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04¿ù 16ÀÏ  12:40~12:45 Break  () 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ12:45~13:05 How to Manage &quotAge  Steven Deitelzweig(Ochsner. US) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ13:05~13:25 What Are the Characteristics of AF in Asian Patients? Addressing Issues and Challenges  ±èÅÂÈÆ(¿¬¼¼ÀÇ´ë) 
È޽Ġ04¿ù 16ÀÏ  13:25~13:40 Break  () 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ12:45~14:30 Abstract/Case Session  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ14:30~14:45 Hypertension and AF: Pathophysiologic Considerations  Á¶¿µÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ14:45~15:00 Blood Pressure Variability and New On AF  ±ÇâÈñ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ15:00~15:15 Hypertension and AF: Preventive and Therapeutic Implications  ÁøÀº¼±(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ15:15~15:30 Hypertension and AF: Epidemiology in Korea  À̼ҷÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ15:30~15:45 Hypertension and AF: Special Considerations in the Elderly  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀΠ15:45~16:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04¿ù 16ÀÏ  16:00~16:10 Break  () 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ16:10~16:25 How to Assess Complex Congenital Heart Disease: Transthoracic Echocardiography  ±è¿©Çâ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ16:25~16:40 Critical Moment with Tansesophageal Echocardiography  À̽¾Æ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ16:40~16:55 Cardiac CT Imaging - Add-on Modality in ACHD Management  °íÈÆ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ16:55~17:10 Right Ventricular Function and More - Cardiac MRI in ACHD  ±è¿µÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀΠ17:10~17:25 Case Based Approach Using Multimodliaty Imaging in ACHD  ¹ÚÁغó(¼­¿ïÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀΠ17:25~17:40 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021 ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¦65Â÷ Ãá°èÇмú´ëȸ : 2021-04-16
´ÙÀ½±Û 2021³â ´ëÇѱٰñ°Ý¿µ»óÀÇÇÐȸ ¿Â¶óÀÎ Á¤±âÇмú´ëȸ : 2021-04-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
135 °æ±â Á¦59ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¼¼¹Ì³ª : 2018-08-26 0 1,837 2018-07-28
134 ¼­¿ï Á¦8ȸ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â¼¾ÅÍ ½ÉÆ÷Áö¾ö(ÁÖÁ¦: ÈçÈ÷ ¸¸³ª°Ô µÇ´Â ¼Ò¾Æû¼Ò³â Áúȯ) : 2018-08-26 0 715 2018-07-28
133 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦9ȸ ¿¬¼¼ÀÇ´ë ¼Ò¾Æ°úÇб³½Ç, ¼Ò¾Æ¾Ë·¹¸£±âÈ£Èí±âÁúȯ ¿¬¼ö°­Á : 2018-08-26 0 395 2018-07-28
132 ¼­¿ï 2018 ´ëÇѼö¸éÇÐȸ ¿öÅ©¼¥ : 2018-08-26 0 482 2018-07-28
131 °æºÏ ´ëÇѼҾưúÇÐȸ ¼Ò¾Æû¼Ò³â°ú ¿Ü·¡¿¡¼­ Àû¿ë °¡´ÉÇÑ ÀÓ»óÁö½Ä : 2018-08-26 0 652 2018-07-28
130 °æ³² ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ 2018 Post Graduate Asthma School (2ÀÏÂ÷) : 2018-08-26 0 1,080 2018-07-28
129 ¼­¿ï Á¦5ȸ ´ëÇÑ°³¿ø³»°úÀÇ»çȸ °¨¿°º´ ¹× ¹é½Å½ÉÆ÷Áö¿ò : 2018-08-26 0 527 2018-07-28
128 ¼­¿ï Á¦15Â÷ °æ±âµµÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 1,154 2018-07-28
127 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ °í/½½°üÀý Áúȯ : 2018-08-25 0 562 2018-07-28
126 ºÎ»ê ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018 ECMO Symposium and Simulation Workshop : 2018-08-25 0 2,513 2018-07-28
125 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_ÃÊÀ½ÆÄ¿öÅ©¼ó : 2018-08-25 0 626 2018-07-28
124 ´ëÀü Ãæ³²´ëÇб³º´¿ø Ãæ³²´ëÇб³ ½Å°æ¿Ü°ú ȨĿ¹Ö ½ÉÆ÷Áö¿ò : 2018-08-25 0 902 2018-07-28
123 °æºÏ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of ASCO 2018 in Korea : 2018-08-25 0 523 2018-07-28
122 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-25 0 384 2018-07-28
121 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¼ö¸éÀÇÇÐ:´ÙÇÐÁ¦ Áø·áÀÇ ÀüÇü : 2018-08-25 0 797 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷